Hospital Clínic de Barcelona

Allogeneic hematopoietic cell transplantation in older myelofibrosis patients: A study of the chronic malignancies working party of EBMT and the Spanish Myelofibrosis Registry (2021) Hernandez-Boluda JC, Pereira A, Kroeger N, Cornelissen JJ, Finke J, Beelen D, De Witte M, et al. Journal article Abatacept Reverses Subclinical Arthritis in Patients with High-risk to Develop Rheumatoid Arthritis -results from the Randomized, Placebo-controlled ARIAA Study in RA-at Risk Patients (2021) Rech J, Hueber A, Ostergaard M, Tascilar K, Hagen M, Mendez LV, Kleyer A, et al. Conference contribution How COVID-19 kick-started online learning in medical education-The DigiMed study (2021) Stoehr F, Müller L, Brady A, Trilla A, Mähringer-Kunz A, Hahn F, Düber C, et al. Journal article Sirolimus in renal transplant recipients with malignancies in Germany (2021) Naik MG, Arns W, Budde K, Diekmann F, Eitner F, Gwinner W, Heyne N, et al. Journal article European Myeloma Network perspective on CAR T-cell therapies for multiple myeloma (2021) Bruno B, Wasch R, Engelhardt M, Gay F, Giaccone L, D'Agostino M, Rodriguez-Lobato LG, et al. Journal article, Review article Development of randomized trials in adults with medulloblastoma—the example of eortc 1634-btg/noa-23 (2021) Hau P, Frappaz D, Hovey E, Mccabe MG, Pajtler KW, Wiestler B, Seidel C, et al. Journal article Digital Support to Multimodal Community-Based Prehabilitation: Looking for Optimization of Health Value Generation (2021) Barberan-Garcia A, Cano I, Bongers BC, Seyfried S, Ganslandt T, Herrle F, Martinez-Palli G Journal article Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group (2021) Moreau P, Kumar SK, San Miguel J, Davies F, Zamagni E, Bahlis N, Ludwig H, et al. Journal article, Review article Response to Escande et al.: Magnetic guided brachytherapy: Time for non-pelvic cancer? Example from tongue brachytherapy [1] (2021) Kovács G, Martinez-Monge R, Budrukkar A, Guinot JL, Johansson B, Strnad V, Rovirosa A, et al. Journal article Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): health-related quality-of-life results from a double-blind, randomised, controlled, phase 3 trial. (2021) Bottomley A, Coens C, Mierzynska J, Blank CU, Mandalà M, Long GV, Atkinson VG, et al. Journal article